Clinical Trial Update: CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease [NA]

View source ↗

Summary

This entry describes a recruiting clinical trial evaluating CSF analysis in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: EGFR Activating Mutation, Leptomeningeal Metastasis | NA | Status: RECRUITING